Peter Sedlmayr

Monocyte-mediated T-cell suppression and augmented monocyte tryptophan catabolism after human hematopoietic stem-cell transplantation.

Indoleamine 2,3-dioxygenase in materno-fetal interaction.

High availability of intravascular tissue factor in neonates.

Automatic retrieval of single microchimeric cells and verification of identity by on-chip multiplex PCR.

A new method for morphometric analysis of tissue distribution of mobile cells in relation to immobile tissue structures.

Combined molecular genetic and cytogenetic analysis from single cells after isothermal whole-genome amplification.

Vascular endothelial expression of indoleamine 2,3-dioxygenase 1 forms a positive gradient towards the feto-maternal interface.

Amnion-derived mesenchymal stromal cells show angiogenic properties but resist differentiation into mature endothelial cells.

Placental expression of indoleamine 2,3-dioxygenase.

Characterization of the conditioned medium from amniotic membrane cells: prostaglandins as key effectors of its immunomodulatory activity.

Are morphological criteria sufficient for the identification of circulating tumor cells in renal cancer?

The role of placental tryptophan catabolism.

Catch and Release: rare cell analysis from a functionalised medical wire.

Visualization of tumor heterogeneity by in situ padlock probe technology in colorectal cancer.

Multiplex Gene Expression Profiling of In Vivo Isolated Circulating Tumor Cells in High-Risk Prostate Cancer Patients.

In Situ Detection and Quantification of AR-V7, AR-FL, PSA, and Point Mutations in Circulating Tumor Cells.

Endothelial indoleamine 2,3-dioxygenase-1 regulates the placental vascular tone and is deficient in intrauterine growth restriction and pre-eclampsia.